Keywords: adjuvants, cancer immunotherapy, immunotherapeutics, NOD1 agonists, NOD1 antagonists, NOD2 agonists, NOD2 antagonistsFull text (file, 2,15 MB) This document has more files! More...
Keywords: type 2 diabetes mellitus, obesity, GLP‐1 receptor agonists, incretins, cardiovascular safety, genetic polymorphismsFull text (file, 1,07 MB) This document has more files! More...
Keywords: 3T3 embryonic cells, astrocytes, aerobic glycolysis, cytosolic L-lactate, FRET nanosensor, G-protein-coupled receptors, GPR27, agonistsFull text (file, 24,11 MB) This document has more files! More...
Keywords: NOD2, desmuramylpeptide, immunostimulant, adamantane, PBMC cytotoxicity, K562, agonists, cells, peptides and proteins, reaction products, toxicological synergyFull text (file, 2,68 MB) This document has more files! More...